David Song

Differential neuropathological alterations in transgenic mice expressing α‐synuclein from the platelet‐derived growth factor and Thy‐1 promoters

Edward Rockenstein, Margaret Mallory, Makoto Hashimoto et al. · Journal of Neuroscience Research · 2002 · 493 citations

Enhanced substantia nigra mitochondrial pathology in human α-synuclein transgenic mice after treatment with MPTP111-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

David Song, Clifford W. Shults, Abbyann Sisk et al. · Experimental Neurology · 2003 · 292 citations

Neurodegenerative Diseases, Molecular Neuroscience, Mitochondrial Function +9

Neurological and Neurodegenerative Alterations in a Transgenic Mouse Model Expressing Human α-Synuclein under Oligodendrocyte Promoter: Implications for Multiple System Atrophy

Clifford W. Shults, Edward Rockenstein, Leslie Crews et al. · Journal of Neuroscience · 2005 · 254 citations · Full text

Pilot trial of high dosages of coenzyme Q10 in patients with Parkinson's disease

Clifford W. Shults, M. Flint Beal, David Song et al. · Experimental Neurology · 2004 · 221 citations

Pilot Trial, Coenzyme Q10, Psychotropic Medication +6

Striatal Responses to Partial Dopaminergic Lesion: Evidence for Compensatory Sprouting

David Song, Suzanne N. Haber · Journal of Neuroscience · 2000 · 160 citations · Full text

Neurodegenerative Diseases, Neurobiological Mechanism, Brain Function +14